Retatrutide
A synthetic peptide reference material studied in the published literature as a multi-receptor incretin agonist.
- Material
- Retatrutide
- Form
- Lyophilized powder
- Vial quantity
- 10 mg · 1 vial
- Batch number
- LAN-RETA-2608-01
- Testing status
- Testing in progress
- Storage
- Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Supplied for laboratory research use only. Not for human or veterinary use.
Current Batch Analysis
Batch: LAN-RETA-2608-01
- Identity
- Pending
- Quantity
- Pending
- Purity
- Pending
- Additional testing
- —
- Independent laboratory
- Pending
- Testing date
- —
Analytical testing in progress. Results and the original laboratory report will be published here once received.
Material Overview
Retatrutide (research designation LY3437943) is a synthetic peptide investigated in published research as an agonist at GIP, GLP-1 and glucagon receptors. Supplied strictly as a reference material for in-vitro laboratory research.
Research Context
Retatrutide has been described in peer-reviewed literature investigating triple incretin receptor pharmacology. Published clinical research is conducted under regulated trial conditions and is unrelated to the supply of reference material.
Storage & Handling
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Molecular Information
- Peptide sequence
- Proprietary synthetic sequence (see supplier documentation)
- Molecular formula
- C221H342N46O68
- Molecular weight
- 4731.3 g/mol
- CAS number
- 2381089-83-2
- Synonyms
- LY3437943
- Research classification
- Single peptide reference material